Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MUC1 expression in hematopoietic tissues.

G A Dent1, C J Civalier, M E Brecher

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill 27599-7525, USA.

American Journal of Clinical Pathology
|June 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Normovolemic Hemodilution in Surgery.

Hematology (Amsterdam, Netherlands)·2016
Same author

The University of North Carolina at Chapel Hill School of Medicine.

Academic medicine : journal of the Association of American Medical Colleges·2010
Same author

Detection of bacterial contamination of platelet concentrates.

Vox sanguinis·2007
Same author

Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.

Transfusion·2005
Same author

Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit.

Transfusion·2005
Same author

Severe hemolytic anemia due to auto anti-N.

Immunohematology·2005
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

MUC1 gene expression, initially proposed for detecting breast cancer micrometastases, is widespread in hematopoietic tissues. This study confirms MUC1 is unsuitable as a specific marker for epithelial micrometastases due to its ubiquitous presence in blood and bone marrow cells.

Area of Science:

  • Molecular biology
  • Cancer diagnostics
  • Immunology

Background:

  • The MUC1 gene encodes the core protein of episialin, a target for cancer detection.
  • Reverse transcription-polymerase chain reaction (RT-PCR) has been explored for detecting MUC1 transcripts in micrometastases.
  • Previous reports suggested MUC1 expression in hematopoietic tissues, but confirmation was lacking.

Purpose of the Study:

  • To investigate MUC1 expression in hematopoietic tissues.
  • To evaluate the suitability of MUC1 as a marker for epithelial micrometastases from breast cancer.
  • To characterize MUC1 protein products in various cell types.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) to detect MUC1 transcripts.
  • Western blot analysis using anti-MUC1 core and anti-epithelial membrane antigen (EMA) antibodies.

Related Experiment Videos

  • Analysis of peripheral blood, bone marrow, lymph node samples, and hematopoietic cell lines.

    • Main Results:

    • MUC1 expression was detected by RT-PCR in peripheral blood, bone marrow, and lymph node samples.
    • Western blot analysis confirmed MUC1 expression (both 68-kd core and high molecular weight EMA products) in peripheral blood and bone marrow.
    • Lymph node samples showed EMA reactivity, with less prominent 68-kd product; MUC1 was expressed in various hematopoietic cell lines.

    Conclusions:

    • MUC1 is ubiquitously expressed in hematopoietic tissues.
    • MUC1 is not a suitable marker for detecting epithelial micrometastases due to its widespread presence in non-epithelial cells.
    • Further research is needed to identify specific markers for micrometastasis detection.